Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911341716> ?p ?o ?g. }
- W2911341716 endingPage "2020" @default.
- W2911341716 startingPage "2009" @default.
- W2911341716 abstract "Abstract Enhancer of zeste homolog (EZH2) is a key epigenetic regulator of gene expression and is frequently overexpressed in various cancer types, suggesting a role in oncogenesis. The therapeutic potential of EZH2 inhibitors is currently being explored, but their effect on antitumor immunity is largely unknown. Here we report that suppressing EZH2 activity using EZH2 inhibitor GSK126 resulted in increased numbers of myeloid-derived suppressor cells (MDSC) and fewer CD4+ and IFNγ+CD8+ T cells, which are involved in antitumor immunity. Addition of a neutralizing antibody against the myeloid differentiation antigen GR-1 or gemcitabine/5-fluorouracil–depleted MDSCs alleviated MDSC-mediated immunosuppression and increased CD4+ and CD8+ T-cell tumor infiltration and GSK126 therapeutic efficacy. Mechanistically, we identified a novel pathway of MDSC production in cancer in which EZH2 inhibition directs myeloid differentiation from primitive hematopoietic progenitor cells. These findings suggest that modulating the tumor immune microenvironment may improve the efficacy of EZH2 inhibitors. Significance: This study uncovers a potential mechanism behind disappointing results of a phase I clinical trial of EZH2 inhibitor GSK126 and identifies a translatable combinational strategy to overcome it." @default.
- W2911341716 created "2019-02-21" @default.
- W2911341716 creator A5010422757 @default.
- W2911341716 creator A5012357806 @default.
- W2911341716 creator A5017181809 @default.
- W2911341716 creator A5025977715 @default.
- W2911341716 creator A5027652148 @default.
- W2911341716 creator A5038721944 @default.
- W2911341716 creator A5044604634 @default.
- W2911341716 creator A5054322103 @default.
- W2911341716 creator A5086183522 @default.
- W2911341716 date "2019-04-15" @default.
- W2911341716 modified "2023-10-17" @default.
- W2911341716 title "EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells" @default.
- W2911341716 cites W1839228665 @default.
- W2911341716 cites W1995769259 @default.
- W2911341716 cites W2002801575 @default.
- W2911341716 cites W2004380688 @default.
- W2911341716 cites W2010711123 @default.
- W2911341716 cites W2011088911 @default.
- W2911341716 cites W2013149980 @default.
- W2911341716 cites W2013220243 @default.
- W2911341716 cites W2015346703 @default.
- W2911341716 cites W2030342863 @default.
- W2911341716 cites W2037805235 @default.
- W2911341716 cites W2048122601 @default.
- W2911341716 cites W2053116646 @default.
- W2911341716 cites W2057851955 @default.
- W2911341716 cites W2060608189 @default.
- W2911341716 cites W2079068389 @default.
- W2911341716 cites W2083898865 @default.
- W2911341716 cites W2087555008 @default.
- W2911341716 cites W2099869529 @default.
- W2911341716 cites W2100365251 @default.
- W2911341716 cites W2103021272 @default.
- W2911341716 cites W2121250734 @default.
- W2911341716 cites W2141410747 @default.
- W2911341716 cites W2160689782 @default.
- W2911341716 cites W2164052369 @default.
- W2911341716 cites W2167957194 @default.
- W2911341716 cites W2176126538 @default.
- W2911341716 cites W2177432730 @default.
- W2911341716 cites W2199397492 @default.
- W2911341716 cites W2202401513 @default.
- W2911341716 cites W2215578332 @default.
- W2911341716 cites W2260219310 @default.
- W2911341716 cites W2264682687 @default.
- W2911341716 cites W2593014410 @default.
- W2911341716 cites W2608294885 @default.
- W2911341716 cites W2775941399 @default.
- W2911341716 cites W2790566984 @default.
- W2911341716 cites W2792926177 @default.
- W2911341716 doi "https://doi.org/10.1158/0008-5472.can-18-2395" @default.
- W2911341716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30737232" @default.
- W2911341716 hasPublicationYear "2019" @default.
- W2911341716 type Work @default.
- W2911341716 sameAs 2911341716 @default.
- W2911341716 citedByCount "104" @default.
- W2911341716 countsByYear W29113417162019 @default.
- W2911341716 countsByYear W29113417162020 @default.
- W2911341716 countsByYear W29113417162021 @default.
- W2911341716 countsByYear W29113417162022 @default.
- W2911341716 countsByYear W29113417162023 @default.
- W2911341716 crossrefType "journal-article" @default.
- W2911341716 hasAuthorship W2911341716A5010422757 @default.
- W2911341716 hasAuthorship W2911341716A5012357806 @default.
- W2911341716 hasAuthorship W2911341716A5017181809 @default.
- W2911341716 hasAuthorship W2911341716A5025977715 @default.
- W2911341716 hasAuthorship W2911341716A5027652148 @default.
- W2911341716 hasAuthorship W2911341716A5038721944 @default.
- W2911341716 hasAuthorship W2911341716A5044604634 @default.
- W2911341716 hasAuthorship W2911341716A5054322103 @default.
- W2911341716 hasAuthorship W2911341716A5086183522 @default.
- W2911341716 hasBestOaLocation W29113417161 @default.
- W2911341716 hasConcept C104317684 @default.
- W2911341716 hasConcept C109159458 @default.
- W2911341716 hasConcept C121608353 @default.
- W2911341716 hasConcept C167672396 @default.
- W2911341716 hasConcept C179185449 @default.
- W2911341716 hasConcept C185592680 @default.
- W2911341716 hasConcept C203014093 @default.
- W2911341716 hasConcept C2776885095 @default.
- W2911341716 hasConcept C2779282312 @default.
- W2911341716 hasConcept C28328180 @default.
- W2911341716 hasConcept C41091548 @default.
- W2911341716 hasConcept C50171091 @default.
- W2911341716 hasConcept C502942594 @default.
- W2911341716 hasConcept C54355233 @default.
- W2911341716 hasConcept C55493867 @default.
- W2911341716 hasConcept C55721878 @default.
- W2911341716 hasConcept C86803240 @default.
- W2911341716 hasConcept C8891405 @default.
- W2911341716 hasConcept C95444343 @default.
- W2911341716 hasConceptScore W2911341716C104317684 @default.
- W2911341716 hasConceptScore W2911341716C109159458 @default.
- W2911341716 hasConceptScore W2911341716C121608353 @default.
- W2911341716 hasConceptScore W2911341716C167672396 @default.
- W2911341716 hasConceptScore W2911341716C179185449 @default.